Rilpivirine hydrochloride

Drug ingredient

CAS 700361-47-3

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 700361-47-3
1 HCl
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

17 FDA-registered drug labelers
Aurore pharmaceuticals private limited
Cilag AG
Cipla Ltd.
Gilead Sciences, Inc.
Glaxo Operations UK Ltd
Hetero Drugs Limited
Janssen Pharmaceutical Sciences Unlimited Company
Janssen Products, LP
Laurus Labs Limited
MSN Pharmachem Private Limited
Mylan Pharmaceuticals Inc.
Patheon Inc.
Rottendorf Pharma GmbH
SMS Pharmaceuticals Limited
Somerset Therapeutics, LLC
Teva API India Private Ltd
ViiV Healthcare Company

Why It Matters

Sectors
Health
Downstream Uses

Appears in 8 drug and cosmetic product listings (FDA).

  • •emtricitabine, rilpivirine and tenofovir disoproxil fumarate
  • •Juluca
  • •Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
  • •Edurant PED
  • •Rilpivirine
  • •Edurant
  • •Complera
  • •Odefsey
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS700361-47-3
PubChem CID11711114
DTXSIDDTXSID80220320
FormulaC22H19ClN6
Mol. Weight402.9 g/mol
SMILESCC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.Cl

Data Sources

Brief citations

Rilpivirine hydrochloride (CAS 700361-47-3) https://chemicalindependence.com/chemical/700361-47-3/ PubChem: 11711114. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11711114 FDA National Drug Code directory: CAS 700361-47-3. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/